Intranasal Z Acid Neurotherapy

BRIEF CV OF PROF. ATTA-UR-RAHMAN, FRS Prof. Atta-ur-Rahman obtained his Ph.D. in Organic Chemistry from King’s College, University of Cambridge (1968). He has over 1,616 international publications, including 875 research papers, 92 international patents, 70 book chapters and 399 books (11 authored, 388 edited), with an h-index of 84 and 44,983 citations. He was elected Fellow of the Royal Society (London) (2006), received the UNESCO Science Prize (1999), TWAS Prize for Institution Building (2009), China’s International Science & Technology Cooperation Award (2020), and is Foreign Academician of the Chinese Academy of Sciences and Fellow of KAST. He is also an Honorary Life Fellow of King’s College Cambridge and recipient of four major Pakistani civil awards, including Nishan-i-Imtiaz.

Shabana Usman Simjee is a Professor of Pharmacology and an established neuroscientist at the H.E.J. Research Institute of Chemistry, International Center for Chemical and Biological Sciences (ICCBS), University of Karachi. She has been associated with ICCBS since 2004 and holds a PhD in Neuroscience from the University of Manchester, UK, following postgraduate training in biochemistry and health sciences. Her research focuses on neuropharmacology, neuroregeneration, neurogenesis, and neurological disorders, including Alzheimer’s disease, epilepsy, stroke, and CNS tumors. She has extensive experience in multidisciplinary research, international collaborations, postgraduate supervision, scientific publications, patents, and academic leadership.

My research focuses on discovering and developing novel bioactive compounds, antimicrobial peptides, and peptide-based therapeutics for infectious and non-infectious diseases. Our research evaluates natural products, synthetic compounds, and nanoformulations for their antimicrobial, anticancer, antioxidant, and anti-inflammatory activities. Particular emphasis is placed on antimicrobial resistance, biofilm-associated infections, and the molecular mechanisms underlying therapeutic activity. We employ a combination of in vitro and in vivo models to investigate efficacy, toxicity, pharmacological activity, and mechanisms of action. Our research also explores drug repurposing and combination therapy to develop novel therapeutic strategies against challenging diseases.

Dr. Maha Shahid is a neuropharmacologist currently working as an Assistant Professor (IPFP Fellow) at the International Center for Chemical and Biological Sciences, University of Karachi. With over nine years of experience in neuroscience research and teaching, she is passionate about understanding the brain and its ability to adapt, recover, and repair following disease or injury. Her research interests span ischemic stroke, epilepsy, neuro-regeneration, and neurodegenerative disorders, using experimental models to explore new therapeutic possibilities. Her work has contributed to peer-reviewed publications and a filed patent, reflecting her commitment to translating neuroscience discoveries into innovative solutions with real-world potential.

Muhammad Nadeem ul Haque is a Ph.D. chemist with over two years of experience as a Research Officer at IAC, ICCBS. His work primarily focuses on pharmaceutical formulation development, particularly nanoemulsion-based drug formulations, hydrogel development, and chemical analysis. He has hands-on experience with HPLC, FTIR/ATR-FTIR, NMR, and mass spectrometry, along with research project development, spectral interpretation, unknown compound identification, and scientific writing. He applies his practical chemistry expertise to address research and product development challenges.